Clinique UK ads
This article was originally published in The Rose Sheet
Executive Summary
Estee Lauder's Clinique division should not repeat an unsupported magazine advertising claim for Clinique Repairwear, the British Advertising Standards Authority concludes in a case reported on its Web site Oct. 11. The claim in question, "Enables skin to steer hearty cells to the base of a wrinkle and triggers skin's own natural collagen production," was not supported by studies submitted by Clinique, ASA concludes after hiring an independent expert to evaluate the research. "The expert questioned the implication that a topical product could suppress the local immune cells and either turn on collagen production, or increase it," the industry watchdog group says. Separately in the review, Clinique was able to support the ad claim "Creates a visible reduction in the appearance of wrinkles..".
You may also be interested in...
Post-Brexit UK Risks Being ‘Left Out In The Cold’ As EU Coordinates Action On Shortages
The UK is not alone in experiencing drug shortages, as data from across Europe show, but its departure from the EU makes it more difficult to respond to supply chain pressures, according to new research.
Dr Reddy’s Knocked Back On Rituximab In US
Dr Reddy’s has received a complete response letter from the US FDA, knocking back its proposed rituximab biosimilar rival to Rituxan.
Sandoz And Samsung Celebrate Stelara Rival’s EU Approval
Sandoz and Samsung Bioepis have received final European Commission approval for their partnered Pyzchiva biosimilar rival to Stelara. But with European competition on ustekinumab due to kick off in just a matter of months, further applicants are also waiting in the wings.